Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adicet Bio
Adicet Bio
(ACET)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Dactolisib
neoplasms
Bevifimod
uveal neoplasms
,
uveal melanoma
,
neoplasms
,
melanoma
Fluzone
paramyxoviridae infections
,
influenza in birds
,
covid-19
,
multiple sclerosis
,
sclerosis
,
neoplasms
,
virus diseases
,
dengue virus
,
orthomyxoviridae
,
infections
,
communicable diseases
,
infectious myxomatosis
,
h1n1 subtype influenza a virus
,
obesity
,
fever
,
dengue
,
severe dengue
,
viral hemorrhagic fevers
,
hyperthermia
,
whooping cough
,
tetanus
,
diphtheria
,
poliomyelitis
,
tetany
,
meningococcal infections
,
yellow fever
,
haemophilus influenzae type b
,
inactivated vaccines
,
morbid obesity
,
human influenza
,
orthomyxoviridae infections
,
healthy volunteers/patients
,
heart failure
,
stroke
,
myocardial infarction
,
infarction
,
multiple myeloma
,
plasma cell neoplasms
,
plasmacytoma
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
pneumonia
,
pregnancy
,
immune system diseases
,
pregnancy complications
,
micronutrients
,
toxicological phenomena
,
otitis media
,
respiratory syncytial virus infections
,
bronchiolitis
,
otitis
,
only child
,
atrial fibrillation
,
cardiovascular diseases
,
coronary disease
,
cardiac arrhythmias
,
heart arrest
,
emergencies
,
diabetes mellitus
,
respiratory tract infections
,
inferior wall myocardial infarction
,
severe acute respiratory syndrome
,
behavior and behavior mechanisms
,
immunization
Flumist
obesity
,
influenza a virus
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
,
human influenza
,
respiratory tract infections
,
critical illness
,
virus diseases
,
infections
,
communicable diseases
,
herpesviridae infections
,
influenza b virus
,
respiratory syncytial virus infections
,
emergencies
Flucelvax
pneumonia
,
chronic obstructive pulmonary disease
,
pneumococcal pneumonia
,
haemophilus influenzae
,
streptococcus pneumoniae
,
virus diseases
,
respiratory tract diseases
,
respiration disorders
,
arthralgia
,
neisseria meningitidis
,
dengue
,
respiratory syncytial virus infections
,
influenza in birds
,
herpes zoster
,
tetanus
,
diphtheria
,
herpes simplex
,
hepatitis b
,
whooping cough
,
hepatitis
,
poliomyelitis
,
meningococcal infections
,
human influenza
,
h1n1 subtype influenza a virus
,
haemophilus influenzae type b
,
infections
,
common cold
,
healthy volunteers/patients
,
hiv infections
,
otitis media
,
respiratory tract infections
,
communicable diseases
,
disease progression
,
sinusitis
,
asthma
,
bronchitis
,
bronchial spasm
,
multiple sclerosis
,
sclerosis
,
narcolepsy
,
myositis
,
fever
,
infectious encephalitis
,
immunologic tests
,
malaria
,
meningitis
,
pneumococcal infections
,
otitis
,
emergencies
,
drug-related side effects and adverse reactions
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use